1071429-55-4

Basic information

• Product Name: N2-N,N-dimethylaminomethylene-10-formyl-Pte-Glu(NH(Boc-His(τ-Bu-4-yl)OMe))-OtBu
• Synonyms: N2-N,N-dimethylaminomethylene-10-formyl-Pte-Glu(NH(Boc-His(τ-Bu-4-yl)OMe))-OtBu
• CAS NO: 1071429-55-4
• Molecular Weight: 903.008
• Mol File: 1071429-55-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N2-N,N-dimethylaminomethylene-10-formyl-Pte-Glu(NH(Boc-His(τ-Bu-4-yl)OMe))-OtBu(CAS DataBase Reference)
• NIST Chemistry Reference: N2-N,N-dimethylaminomethylene-10-formyl-Pte-Glu(NH(Boc-His(τ-Bu-4-yl)OMe))-OtBu(1071429-55-4)
• EPA Substance Registry System: N2-N,N-dimethylaminomethylene-10-formyl-Pte-Glu(NH(Boc-His(τ-Bu-4-yl)OMe))-OtBu(1071429-55-4)

Safety Data

• Hazardous Substances Data: 1071429-55-4(Hazardous Substances Data)

Upstream product

• 1046806-30-7 N(Τ)-(4-aminobutyl)-N(α)-(tert-butoxycarbonyl)-L-histidine methyl ester 
• 1071429-46-3 N(Τ)-(4-azidobutyl)-N(α)-(tert-butoxycarbonyl)-L-histidine methyl ester 
• 1071429-51-0 N(α)-(tert-butoxycarbonyl)-N(Τ)-(4-{[O(α)-tert-butyl-N(α)-(9H-fluoren-9-ylmethoxycarbonyl)-γ-glutamyl]amino}butyl)-L-histidine methyl ester 
• 119-24-4 pteroic acid 
• 119-20-0 10-formyl-pteroic acid 
• 84793-07-7 Fmoc-Glu-OtBu 
• 200616-38-2 (2S)-N₂-(9-fluorenylmethyloxycarbonyl)-glutamic acid α-tert-butyl ester γ-N-hydroxysuccinimide ester 
• 1071429-48-5 N(α)-(tert-butoxycarbonyl)-N(Τ)-{4-[(O(α)-tert-butyl-γ-glutamyl)amino]butyl}-L-histidine methyl ester 
• 1046806-28-3 N²,N,N-dimethylaminomethylene-10-formyl-pteroic acid 

Downstream Products

• 1046806-32-9 (S)-4-(4-(4-((S)-2-amino-2-carboxyethyl)-1H-imidazol-1-yl)butylcarbonylamino)-2-(4-((2-amino-4-oxo-3,4-dihydropteridin-6-yl)methylamino)benzamido)-4-oxobutanoic acid 

Relevant articles and documents

Synthesis of a novel γ-folic acid-Nτ-histidine conjugate suitable for labeling with99mTc and188Re

Radiolabeled folate derivatives have the potential to target folate receptor-positive tumor cells for noninvasive diagnosis and therapy. We report the synthesis of a novel γ-folic acid-Nτ-his-tidine conjugate 1 wherein the Nτ-histidine is suitable for rad